EFFECTS OF TRAUMA PLASMA-DERIVED EXOSOMES ON HEMATOPOIETIC PROGENITOR CELLS.
Jennifer A Munley, Lauren S Kelly, Gwendolyn S Gillies...
https://pubmed.ncbi.nlm.nih.gov/36772985/Actively Recruiting
Led by University of Florida · Updated on 2026-01-15
400
Participants Needed
1
Research Sites
52 weeks
Total Duration
Traumatic injury is a major cause of illness and death in young adults, leading to significant health and economic challenges. This research aims to understand how severe trauma affects hematopoietic stem cells HSCs in bone marrow and muscle cells, especially in elderly patients compared to non-injured individuals. The study focuses on the bodys emergency response involving myeloid cells and how this response impacts immune function and muscle loss after trauma. Participants are divided into three groups those undergoing elective hip surgery, trauma patients, and healthy bone marrow donors from a tissue bank. Bone marrow and blood samples will be collected during surgery or from the tissue bank. These samples will be analyzed for various factors such as genomic expression, oxidative stress, mitochondrial activity, and immune cell function using laboratory tests including ELISAs and assays for erythropoietin and iron levels. During hospitalization, clinical and hemodynamic data will be collected daily for trauma patients, who will also be monitored for bone healing and need for additional surgery. Researchers will measure genomic responses in hematopoietic cells and assess muscle dysfunction through several biological markers. The study seeks to understand injury-associated anemia and muscle loss, with follow-up care continuing until the study ends.
CONDITIONS
Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury
J
Jennifer D Lanz, MSN
R
Ruth J Davis, ASN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Florida
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Severe Trauma (Orthopedic Repair) | Elective Hip Repair | Healthy Young Bone Marrow Control |
|---|---|---|---|
| What is it? | Adults who have suffered severe blunt or penetrating trauma with long bone or pelvic fractures requiring orthopedic surgical repair. Bone marrow and blood are sampled perioperatively. | Adults undergoing planned hip repair surgery for non-infectious reasons. Bone marrow and blood are collected at the time of surgery. | Healthy young adults who provide bone marrow and blood samples for comparison as controls. |
| Primary research goal | To analyze hematopoietic stem cell function and genomic changes after severe injury in elderly and younger adults compared with control groups. | Serves as a surgical control group to distinguish changes due to trauma from changes related merely to orthopedic surgery. | Provides baseline data on bone marrow and blood characteristics in young, healthy individuals for comparison with the trauma and surgery groups. |
| Evidence status | Ongoing collection of bone marrow and blood in the setting of severe trauma; published studies show trauma is linked to changes in bone marrow progenitor cell activity and gene expression. | Samples from patients undergoing planned hip repair serve as a surgical reference group; evidence supports differences versus traumatic injury responses. | Healthy control samples establish baseline bone marrow and blood biology, referenced in trauma and bone marrow dysfunction studies. |
| Important limitations | Participant health at sampling may be affected by trauma severity, resuscitation, or timing of surgery. Laboratory measurements may vary due to emergency conditions. Does not evaluate a treatment or intervention outcome. | Findings may not generalize beyond orthopedic surgical patients; not designed to assess trauma response or interventions. Potential demographic or health status differences may influence results. | Healthy controls may differ substantially in age and comorbidities from the trauma and surgical groups. Results may not reflect normal values for all adults, particularly the elderly. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - Day of surgery
Participants undergo orthopedic repair surgery during which bone marrow and blood samples are collected.
1 visit (in-person)
Duration - Duration of hospitalization
Participants may have additional bone marrow and blood samples collected if they require return to the operating room for further repair of orthopedic injury. Clinical data and hemodynamic measurements are collected daily while hospitalized.
Daily assessments during hospital stay
Duration - Up to several weeks post-surgery depending on recovery
Trauma surgery participants are followed to evaluate for malunion and any additional surgical procedures for repair.
Follow-up visits as needed based on recovery
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Jennifer A Munley, Lauren S Kelly, Gwendolyn S Gillies...
https://pubmed.ncbi.nlm.nih.gov/36772985/Jennifer A Munley, Micah L Willis, Gwendolyn S Gillies...
https://pubmed.ncbi.nlm.nih.gov/38151766/University of Florida
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborating Sponsor